Skip to main content
EVO
NASDAQ Life Sciences

Goldman Sachs Group Significantly Increases Stake in Evotec SE to 6.12%

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
7
Price
$3.43
Mkt Cap
$1.24B
52W Low
$2.84
52W High
$4.8
Market data snapshot near publication time

summarizeSummary

Goldman Sachs Group reported increasing its total stake in Evotec SE to 6.12% through instruments, signaling increased institutional interest, while MAK Capital also raised its holdings.


check_boxKey Events

  • Goldman Sachs Increases Holdings

    The Goldman Sachs Group, Inc. reported increasing its total stake in Evotec SE to 6.12% as of January 13, 2026, primarily through instruments. This represents a 2.44% increase from its position on January 9, valued at approximately $14.89 million.

  • MAK Capital Increases Holdings

    Michael Kaufman and MAK Capital Fund LP increased their combined stake in Evotec SE to 5.17% as of January 9, 2026, primarily through direct shareholdings. This is a net increase of 0.14% from their previous position, valued at approximately $0.85 million.

  • Prior Goldman Sachs Reduction

    On January 9, 2026, Goldman Sachs had reported a temporary reduction in its total stake to 3.68% from a previous 5.27%, valued at approximately $8.66 million.


auto_awesomeAnalysis

The filing indicates a notable increase in institutional ownership for Evotec SE. The Goldman Sachs Group, Inc. reported a significant increase in its total stake to 6.12% as of January 13, 2026, primarily through instruments. This latest move represents a substantial acquisition, following a temporary reduction earlier in January, and suggests renewed and stronger institutional confidence in the company. Additionally, Michael Kaufman and MAK Capital Fund LP also increased their combined stake to 5.17% on January 9, further contributing to a positive investor sentiment regarding the company's ownership structure.

At the time of this filing, EVO was trading at $3.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $2.84 to $4.80. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed EVO - Latest Insights

EVO
Apr 24, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
7
EVO
Apr 08, 2026, 11:56 AM EDT
Filing Type: 6-K
Importance Score:
8
EVO
Apr 08, 2026, 11:52 AM EDT
Filing Type: 20-F
Importance Score:
8
EVO
Apr 07, 2026, 12:44 PM EDT
Filing Type: 6-K
Importance Score:
9
EVO
Apr 06, 2026, 12:56 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
EVO
Mar 30, 2026, 8:29 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
EVO
Mar 10, 2026, 6:00 AM EDT
Filing Type: 6-K
Importance Score:
9
EVO
Jan 16, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
EVO
Jan 13, 2026, 7:32 AM EST
Filing Type: 6-K
Importance Score:
8
EVO
Jan 08, 2026, 10:09 AM EST
Filing Type: 6-K
Importance Score:
7